Kopsanone inhibits proliferation and migration of invasive colon cancer cells

Colorectal cancer (CRC) is the second leading cause of cancer‐related death globally. In spite of the increasing knowledge on molecular characteristics of different cancer types including CRC, there is limitation in the development of an effective treatment. The present study aimed to verify the ant...

Full description

Saved in:
Bibliographic Details
Published inPhytotherapy research Vol. 35; no. 7; pp. 3769 - 3780
Main Authors Bonfim, Daniella Paiva, Nakamura, Celso Vataru, Araújo Júnior, João Xavier, Pessini, Greisiele Lorena, Leite, Paulo Emílio Correa, Morgado‐Díaz, José Andrés, Leve, Fernanda
Format Journal Article
LanguageEnglish
Published Chichester, UK John Wiley & Sons, Ltd 01.07.2021
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Colorectal cancer (CRC) is the second leading cause of cancer‐related death globally. In spite of the increasing knowledge on molecular characteristics of different cancer types including CRC, there is limitation in the development of an effective treatment. The present study aimed to verify the antitumor effect of kopsanone, an indole alkaloid. To achieve this, we treated human colon cancer cells (Caco‐2 and HCT‐116) with kopsanone and analyzed its effects on cell viability, cell–cell adhesion, and actin cytoskeleton organization. In addition, functional assays including micronuclei formation, colony formation, cell migration, and invasiveness were performed. We observed that kopsanone reduced viability and proliferation and induced micronuclei formation of HCT‐116 cells. Also, kopsanone inhibited anchorage‐dependent colony formation and modulated adherens junctions (AJs), thus increasing the localization of E‐cadherin and β‐catenin in the cytosol of the invasive cells. Finally, fluorescence assays showed that kopsanone decreased stress fibers formation and reduced migration but not invasion of HCT‐116 cells. Taken together, these findings indicate that kopsanone reduces proliferation and migration of HCT‐116 cells via modulation of AJs and can therefore be considered for future in vivo and clinical investigation as potential therapeutic agent for treatment of CRC.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0951-418X
1099-1573
DOI:10.1002/ptr.7078